User profiles for "author:George Pentheroudakis"

George Pentheroudakis

Department of Medical Oncology, University of Ioannina
Verified email at uoi.gr
Cited by 21738

Cancer of unknown primary site

N Pavlidis, G Pentheroudakis - The Lancet, 2012 - thelancet.com
Cancer of unknown primary site (CUP) is a well recognised clinical disorder, accounting for
3–5% of all malignant epithelial tumours. CUP is clinically characterised as an aggressive …

Cancer and pregnancy: poena magna, not anymore

G Pentheroudakis, N Pavlidis - European Journal of Cancer, 2006 - Elsevier
Cancer diagnosed during pregnancy constitutes a difficult clinical condition with a
devastating impact on the patient's somatic and psychosocial health and possibly on foetal …

Switching benchmarks in cancer of unknown primary: from autopsy to microarray

G Pentheroudakis, V Golfinopoulos… - European journal of cancer, 2007 - Elsevier
INTRODUCTION: Cancer of unknown primary (CUP) is associated with unknown biology
and dismal prognosis. Information on the primary site of origin is scant and has never been …

Cancer, pregnancy and fertility: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

FA Peccatori, HA Azim, R Orecchia… - Annals of …, 2013 - annalsofoncology.org
Over the past four decades, there has been a rising trend of delaying childbearing [1]. Given
that cancer incidence increases with age, more women are either diagnosed with cancer …

[HTML][HTML] ESMO recommendations on the use of circulating tumour DNA assays for patients with cancer: a report from the ESMO Precision Medicine Working Group

J Pascual, G Attard, FC Bidard, G Curigliano… - Annals of …, 2022 - Elsevier
Circulating tumour DNA (ctDNA) assays conducted on plasma are rapidly developing a
strong evidence base for use in patients with cancer. The European Society for Medical …

[HTML][HTML] Cancers of unknown primary site: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

K Fizazi, FA Greco, N Pavlidis, G Daugaard… - Annals of …, 2015 - annalsofoncology.org
Cancers of unknown primary site (CUPs) represent a heterogeneous group of metastatic
tumours for which a standardised diagnostic work-up fails to identify the site of origin at the …

[HTML][HTML] Managing cancer patients during the COVID-19 pandemic: an ESMO multidisciplinary expert consensus

G Curigliano, S Banerjee, A Cervantes, MC Garassino… - Annals of …, 2020 - Elsevier
We established an international consortium to review and discuss relevant clinical evidence
in order to develop expert consensus statements related to cancer management during the …

Prognosis of pregnancy-associated breast cancer: a meta-analysis of 30 studies

HA Azim Jr, L Santoro, W Russell-Edu… - Cancer treatment …, 2012 - Elsevier
BACKGROUND: Pregnancy-associated breast cancer (PABC) is relatively rare with
considerable controversy regarding its prognosis. PATIENTS & METHODS: Two of the …

[HTML][HTML] Systemic treatment-induced gastrointestinal toxicity: incidence, clinical presentation and management

S Boussios, G Pentheroudakis, K Katsanos… - Annals of …, 2012 - ncbi.nlm.nih.gov
The toxicity of cancer chemotherapy is among the most important factors limiting its use.
Clear delineation and communication of benefits and risks is an essential component of …

Management of patients with recurrent/advanced cervical cancer beyond first line platinum regimens: Where do we stand? A literature review

S Boussios, E Seraj, G Zarkavelis, D Petrakis… - Critical reviews in …, 2016 - Elsevier
Background Cervical cancer is the fourth most common cancer affecting women worldwide.
Despite advances in screening and human papillomavirus (HPV) vaccination, a significant …